List view / Grid view

Emilie Plantamura (MaaT Pharma)

 

article

Advancing microbiome innovation

In the fourth instalment of EPR's ‘Microbiome therapeutics: microscope to…

10 April 2024 | By

In the fourth instalment of EPR's ‘Microbiome therapeutics: microscope to medicine’ series, Emilie Plantamura, Deputy Chief Medical Officer at MaaT Pharma, examines the promising potential of microbiome therapeutics beyond Clostridium difficile infection, particularly in the onco-haematological field.